Larvol Delta - A-SARSCoV2-neutralizing-antibody-selected-from-COVID19-patients-binds-to-the-ACE2RBD-interface-and-is-tolerant-to-most-known-RBD-mutations

COR-101 - Corat Therap, Dermapharm

http://www.ncbi.nlm.nih.gov/pubmed/34273271

Jul 18, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next